Ocera Therapeutics, Inc.

CIK 1274644 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ocera Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2018SC 13G/A0000930413-18-000496
Feb 14, 2018SC 13G/A0001193125-18-045274
Dec 21, 2017SC 13D/A0001193125-17-375059
Dec 21, 201715-12B0001193125-17-376512
Dec 14, 2017SC 13D/A0000904454-17-000731
Dec 13, 2017EFFECT9999999995-17-003212
Dec 13, 201740000904454-17-000722
Dec 13, 201740000904454-17-000725
Dec 13, 201740000904454-17-000720
Dec 13, 2017EFFECT9999999995-17-003213
Dec 13, 201740000904454-17-000727
Dec 13, 2017EFFECT9999999995-17-003211
Dec 13, 201740000904454-17-000718
Dec 11, 2017S-8 POS0001193125-17-365702
Dec 11, 201725-NSE0001354457-17-000253
Dec 11, 201740000899243-17-028414
Dec 11, 201740000899243-17-028423
Dec 11, 2017POS AM0001193125-17-365728
Dec 11, 2017S-8 POS0001193125-17-365708
Dec 11, 2017POS AM0001193125-17-365723
Dec 11, 201740000899243-17-028418
Dec 11, 2017SC 14D9/A0001193125-17-365681
Dec 11, 2017S-8 POS0001193125-17-365706
Dec 11, 2017S-8 POS0001193125-17-365715
Dec 11, 201740000899243-17-028412